• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation.

作者信息

Crocchiolo Roberto

机构信息

Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy.

出版信息

Blood Transfus. 2024 Mar;22(2):93-95. doi: 10.2450/BloodTransfus.630. Epub 2023 Sep 21.

DOI:10.2450/BloodTransfus.630
PMID:37847209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10920066/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1701/10920066/5db104f67c18/BLT-22-093_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1701/10920066/5db104f67c18/BLT-22-093_g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1701/10920066/5db104f67c18/BLT-22-093_g001.jpg

相似文献

1
Toward a definition of immunological risk for patients with anti-HLA antibodies before stem cell transplantation.迈向干细胞移植前抗HLA抗体患者免疫风险的定义。
Blood Transfus. 2024 Mar;22(2):93-95. doi: 10.2450/BloodTransfus.630. Epub 2023 Sep 21.
2
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.造血干细胞移植中的供体特异性抗 HLA 抗体。单中心前瞻性评估和脱敏策略的应用。
Blood Transfus. 2024 Mar;22(2):157-165. doi: 10.2450/BloodTransfus.464. Epub 2023 Sep 21.
3
The role of anti-HLA antibodies in hematopoietic stem cell transplantation.抗 HLA 抗体在造血干细胞移植中的作用。
Biol Blood Marrow Transplant. 2011 Nov;17(11):1585-8. doi: 10.1016/j.bbmt.2011.06.004. Epub 2011 Jun 16.
4
Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.基于造血细胞和非造血细胞的活体供肾移植免疫耐受诱导策略：一项系统综述。
Transplant Rev (Orlando). 2023 Dec;37(4):100792. doi: 10.1016/j.trre.2023.100792. Epub 2023 Aug 19.
5
Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.利妥昔单抗联合供者血小板输注降低供者特异性抗 HLA 抗体以促进单倍体相合移植中干细胞植入。
J Clin Lab Anal. 2020 Jul;34(7):e23261. doi: 10.1002/jcla.23261. Epub 2020 Feb 28.
6
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.抗 HLA 抗体患者行单倍体造血干细胞移植后移植物失功风险高。
Transplantation. 2009 Oct 27;88(8):1019-24. doi: 10.1097/TP.0b013e3181b9d710.
7
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.供者特异性抗 HLA 抗体与匹配的无关供者造血干细胞移植中的移植物失功。
Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.
8
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.同种异体造血干细胞移植后预防抗体介导排斥反应的免疫调节。
Transpl Immunol. 2011 Sep;25(2-3):153-8. doi: 10.1016/j.trim.2011.06.001. Epub 2011 Jun 21.
9
Anti-HLA Antibody Levels Are Associated With the Risk of Graft Failure After Allogeneic Hematopoietic Stem Cell Transplant.抗人白细胞抗原抗体水平与异基因造血干细胞移植后移植物失败风险相关。
Exp Clin Transplant. 2017 Feb;15(Suppl 1):219-223. doi: 10.6002/ect.mesot2016.P99.
10
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.HLA 同基因兄弟姐妹间联合肾和造血干细胞移植诱导特异性免疫耐受的成功。
Front Immunol. 2022 Jan 31;13:796456. doi: 10.3389/fimmu.2022.796456. eCollection 2022.

引用本文的文献

1
Successful treatment of refractory donor-specific-human leukocyte antigen-antibody-induced primary graft-failure with daratumumab: A case report.达雷妥尤单抗成功治疗难治性供者特异性人类白细胞抗原抗体诱导的原发性移植物功能衰竭：一例报告
EJHaem. 2024 Jun 19;5(4):863-866. doi: 10.1002/jha2.936. eCollection 2024 Aug.

本文引用的文献

1
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.造血干细胞移植中的供体特异性抗 HLA 抗体。单中心前瞻性评估和脱敏策略的应用。
Blood Transfus. 2024 Mar;22(2):157-165. doi: 10.2450/BloodTransfus.464. Epub 2023 Sep 21.
2
Histocompatibility assessment in hematopoietic stem cell transplantation: recommendations from the Italian Society for Immunogenetics and Transplantation Biology (Associazione Italiana di Immunogenetica e Biologia dei Trapianti - AIBT).造血干细胞移植中的组织相容性评估：来自意大利免疫遗传学和移植生物学学会（Associazione Italiana di Immunogenetica e Biologia dei Trapianti - AIBT）的建议。
Blood Transfus. 2024 Jul 12;22(4):338-349. doi: 10.2450/BloodTransfus.495.
3
Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.供者特异性 HLA 抗体与无关供者造血细胞移植后移植物失败和血液学恢复延迟有关。
Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21.
4
Treatment With the Combination of Rituximab and Intravenous γ Globulin Is Effective in Promoting Engraftment in Donor-Specific Antibody Positive Patients Receiving Myeloablative Conditioning Haploidentical Stem Cell Transplantation.利妥昔单抗联合静脉注射丙种球蛋白治疗在接受清髓性单倍体造血干细胞移植的供体特异性抗体阳性患者中促进植入是有效的。
Transplant Cell Ther. 2023 Aug;29(8):514.e1-514.e6. doi: 10.1016/j.jtct.2023.05.005. Epub 2023 May 11.
5
Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT.脐带血移植治疗急性白血病后移植物失败的结果：Eurocord 和 EBMT 急性白血病工作组的一项研究。
Bone Marrow Transplant. 2023 Aug;58(8):936-941. doi: 10.1038/s41409-023-02000-9. Epub 2023 May 10.
6
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation"."在单倍体造血干细胞移植中供体特异性抗体的发生率和意义"。
Bone Marrow Transplant. 2023 Jun;58(6):680-686. doi: 10.1038/s41409-023-01950-4. Epub 2023 Mar 23.
7
Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation-A systematic review and meta-analysis.供者特异性抗体对异基因造血干细胞移植后植入和长期生存的影响：系统评价和荟萃分析。
Bone Marrow Transplant. 2023 May;58(5):544-551. doi: 10.1038/s41409-023-01932-6. Epub 2023 Feb 13.
8
Splenic irradiation combined with plasmapheresis and rituximab: a new option reducing donor-specific antibody in haploidentical hematopoietic stem cell transplantation.脾照射联合血浆置换和利妥昔单抗：一种降低单倍体造血干细胞移植中供者特异性抗体的新选择。
Bone Marrow Transplant. 2023 Feb;58(2):226-228. doi: 10.1038/s41409-022-01868-3. Epub 2022 Nov 19.
9
Presence of antibodies against HLA class I and class II molecules in children before and after allo-HSCT. Alloantibodies before and after HSCT.同种异体 HSCT 前后儿童 HLA Ⅰ类和Ⅱ类分子抗体的存在。HSCT 前后的同种抗体。
HLA. 2023 Jan;101(1):16-23. doi: 10.1111/tan.14817. Epub 2022 Oct 13.
10
Treatment of allosensitized patients receiving allogeneic transplantation.接受同种异体移植的致敏患者的治疗。
Blood Adv. 2021 Oct 26;5(20):4031-4043. doi: 10.1182/bloodadvances.2021004862.